| PD-1/CTLA-4 blockade inhibits Epstein-Barr virus-induced lymphoma growth in a cord blood humanized-mouse model SD Ma, X Xu, R Jones, HJ Delecluse, NA Zumwalde, A Sharma, ... PLoS pathogens 12 (5), e1005642, 2016 | 106 | 2016 |
| Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model NA Zumwalde, A Sharma, X Xu, S Ma, CL Schneider, JC Romero-Masters, ... JCI insight 2 (13), 2017 | 70 | 2017 |
| LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis SD Ma, X Xu, J Plowshay, EA Ranheim, WJ Burlingham, JL Jensen, ... The Journal of clinical investigation 125 (1), 304-315, 2015 | 69 | 2015 |
| CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients X Lin, NH Gudgeon, EP Hui, H Jia, X Qun, GS Taylor, MCNM Barnardo, ... Cancer Immunology, Immunotherapy 57, 963-975, 2008 | 63 | 2008 |
| Development of anti-human mesothelin-targeted chimeric antigen receptor messenger RNA–transfected peripheral blood lymphocytes for ovarian cancer therapy CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley, C Allen, P Natarajan, ... Human gene therapy 29 (5), 614-625, 2018 | 60 | 2018 |
| Long‐term carriers generate Epstein–Barr virus (EBV)‐specific CD4+ and CD8+ polyfunctional T‐cell responses which show immunodominance hierarchies of … RJ Ning, XQ Xu, KH Chan, AKS Chiang Immunology 134 (2), 161-171, 2011 | 49 | 2011 |
| A DNA vaccine protects human immune cells against Zika virus infection in humanized mice G Yi, X Xu, S Abraham, S Petersen, H Guo, N Ortega, P Shankar, ... EBioMedicine 25, 87-94, 2017 | 37 | 2017 |
| Human iNKT cells promote protective inflammation by inducing oscillating purinergic signaling in monocyte-derived DCs X Xu, GM Pocock, A Sharma, SL Peery, JS Fites, L Felley, R Zarnowski, ... Cell reports 16 (12), 3273-3285, 2016 | 23 | 2016 |
| The basics of CAR T design and challenges in immunotherapy of solid tumors—Ovarian cancer as a model X Xu, J Qiu, Y Sun Human vaccines & immunotherapeutics 13 (7), 1548-1555, 2017 | 19 | 2017 |
| 肝积方对中晚期肝癌患者 SIL-2R 及 T 细胞亚群的影响 田华琴， 徐学群， 梁贵文， 黄志庆， 邓健敏 中国现代医学杂志 11 (10), 89-90, 2001 | 11 | 2001 |
| 微剂量肝素治疗急性白血病前 DIC 临床观察 汪宝贞， 余永卫， 周少雄， 吴庆庆， 周润圻， 徐学群， 上官辉 中国实用内科杂志 25 (2), 157-158, 2005 | 6 | 2005 |
| ^(32) P 的无闪烁液测量法研究 刘秀琴， 徐学群 中山医科大学学报 21 (1), 63-65, 2000 | 3 | 2000 |
| 经皮细针穿刺活检诊断浅表占位性病变 30 例 黄志庆， 田华琴， 余寿益， 梁贵文， 徐学群， 邓健敏 中国现代医学杂志 11 (8), 74-74, 2001 | 1 | 2001 |
| 核技术在中药药理研究中的应用现状 徐学群， 刘长征 中山大学学报: 医学科学版, 100-103, 1999 | 1 | 1999 |
| Analysis Of CD4+ And CD8+ Epstein-Barr Virus-Specific Polyfunctional T Cell Responses In Chinese Long Term Carriers By A Novel 9-Colour Flow Cytometric Assay J Ning, X Xu, AKS Chiang Biennial Conference of the International Association for Research on EBV …, 2010 | | 2010 |
| Characterization of CD4+ and CD8+ polyfunctional T cell responses to Epstein-Barr virus (EBV) latent and lytic proteins in Chinese long term carriers J Ning, X Xu, AKS Chiang Research Postgraduate Symposium, RPS 2010, 2010 | | 2010 |
| Detection and tracking of Epstein-Barr Virus (EBV)-specific CD8+ polyfunctional T cells in primary EBV infection X Xu, KH Chan, AKS Chiang AGM & Scientific Meeting of the Hong Kong Society for Immunology, HKSI 2009, 2009 | | 2009 |
| Development of polychromatic flow cytometry assay to study polyfunctional Epstein-Barr Virus (EBV)-specific CD8+ cytotoxic T-lymphocyte responses X Xu, KH Chan, AKS Chiang Biennial Conference of the International Association for Research on EBV …, 2008 | | 2008 |
| Development of latent and lytic Epstein-barr Virus (EBV)-specific CD8+ cytotoxic lymphocyte responses in primary EBV infection X Xu, KH Chan, AKS Chiang Research Postgraduate Symposium, RPS 2007, 2007 | | 2007 |
| Longitudinal study of EBV-specific CD8+ CTL responses in childhood infectious mononucleosis X Xu, GKS Woo, KH Chan, AKS Chiang HKPS-HKPNA 2006 Joint Annual Scientific Meeting, 2006 | | 2006 |
